T-knife Investors

23 investors on Angel Roster list T-knife in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series B and the largest groups are based in the United States, France and Germany.

Investors are matched on the company name in their portfolio, so companies that share the name T-knife can appear together.

Investors listed
23
With verified email
30%
Most common stage
Series B
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 23 T-knife investors

The most complete profiles first. Showing 23 of 23.

  • Brian AtwoodVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsCybersecurityWomen Founded

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 63 more

    Verified email available

  • Debbie LinVerified

    Venture Capital, Corporate Venture Capital, Investor · United States

    SeedHealth CareHospitalsWellnessWomen Founded

    Portfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 36 more

    Verified email available

  • Johannes ZanzingerVerified

    Venture Capital, Corporate Venture Capital, Investor · Germany

    Series BSeries AHealth CareHospitalsWellnessWomen Founded

    Portfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 36 more

    Verified email available

  • Martin HeideckerVerified

    Venture Capital, Corporate Venture Capital, Private Equity Firm · United States

    SeedHealth CareHospitalsWellnessWomen Founded

    Portfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 36 more

    Verified email available

  • Olivier LitzkaVerified

    Venture Capital, Private Equity Firm, Investor · Germany

    Series BHealth CareWearablesHospitalsWellness

    Portfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, Noxxon Pharma and 83 more

    Verified email available

  • Alexander MaywegVerified

    Venture Capital, Private Equity Firm · Switzerland

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more

    Verified email available

  • Detlev MennerichVerified

    Corporate Venture Capital · Germany

    Health CareHospitalsWellnessWomen Founded

    Portfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 35 more

    Verified email available

  • Alexandre Foulon

    Venture Capital, Private Equity Firm, Investor · France

    Series BHealth CareWearablesHospitalsDeepTech

    Portfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more

    Contact details available

  • Arnaud Faure

    Venture Capital, Private Equity Firm, Investor · France

    Series BHealth CareWearablesHospitalsWellness

    Portfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more

    Contact details available

  • Carlo Rizzuto

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 60 more

    Contact details available

  • Charles Warden

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 61 more

    Contact details available

  • Mayeul Caron

    Venture Capital, Private Equity Firm, Investor · France

    Series BHealth CareWearablesHospitalsWellness

    Portfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more

    Contact details available

  • Oliver Reuss

    Venture Capital, Corporate Venture Capital, Investor · Germany

    Series BSeries AHealth CareHospitalsWellnessWomen Founded

    Portfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 35 more

    Contact details available

  • Pierre

    Venture Capital, Private Equity Firm, Investor · France

    Series BHealth CareWearablesHospitalsWellness

    Portfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more

    Contact details available

  • Ross Jaffe

    Venture Capital, Investor · United States

    Series BHealth CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 59 more

    Contact details available

  • Sebastian Kreuz

    Venture Capital, Corporate Venture Capital, Investor · Germany

    Series BSeries AHealth CareHospitalsWellnessWomen Founded

    Portfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 35 more

    Contact details available

  • Beckie Robertson

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more

    Contact details available

  • Bill Link

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more

    Contact details available

  • David Robin

    Venture Capital, Private Equity Firm · France

    Health CareWearablesHospitalsWellness

    Portfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more

    Contact details available

  • Don Milder

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more

    Contact details available

  • Ilka Wicke Dr.

    Corporate Venture Capital · Germany

    Health CareHospitalsWellnessWomen Founded

    Portfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 35 more

    Contact details available

  • Paul Grayson

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more

    Contact details available

  • Pierre Morisseau

    Venture Capital, Private Equity Firm · France

    Health CareWearablesHospitalsWellness

    Portfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many T-knife investors are on Angel Roster?

Angel Roster lists 23 T-knife investors. 7 of them (30%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (21), Private Equity Firms (12) and Corporate Venture Capital Firms (7). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do T-knife investors invest in?

Among those that list a stage, the most common are Series B (9), Seed (5) and Series A (3).

Where are T-knife investors based?

Most are based in the United States (10), France (6) and Germany (6).

Which companies have T-knife investors backed?

The most-backed portfolio companies among them are AgomAb Therapeutics (14), Venatorx Pharmaceuticals (10), Ivantis (9), Intuity Medical (9) and Laguna Pharmaceuticals (9).

How do I contact T-knife investors?

Create a free Angel Roster account to search and filter all 23, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.